Journal Home
Search for

Volume 20, Issue 7, Pages 433-453 (July 2010)


View previous. 2 of 12 View next.

Antidepressants in healthy subjects: What are the psychotropic/psychological effects?

Alessandro SerrettiaCorresponding Author Informationemail address, Raffaella Calatia, Arianna Goraccib, Martina Di Simpliciob, Paolo Castrogiovannib, Diana De Ronchia

Received 22 April 2009; received in revised form 12 November 2009; accepted 22 November 2009. published online 18 January 2010.

Abstract 

A wide debate is ongoing regarding whether antidepressant effects should be considered a general property of these agents or whether they exclusively belong to the context of target symptoms. The aim of the present review is to summarize findings on antidepressant influences on healthy volunteers, focusing on changes in psychological and cognitive functions. Differences have been detected between acute and chronic treatments. Acute treatment has been found to lead to positive bias in emotion processing and facilitation in negative emotion recognition. Chronic treatments have been found to stabilise some changes induced by acute treatment, such as increased social behaviours. Regarding antidepressant modulation of affective symptomatology contrasting results have been reported suggesting that the link between action on cognitive processes and mood may be not direct. In fact, meta-analyzing data on mood and anxiety symptoms no difference was detected between subjects receiving placebo and SSRIs. However, meta-analyzing data on negative affects, a significant decrease was detected in subjects receiving SSRIs in comparison with subjects receiving placebo. In summary, antidepressants seem to exert a detectable influence also in healthy subjects.

a Institute of Psychiatry, University of Bologna, Italy

b Department of Neurosciences, Psychiatry Unit, University of Siena, Italy

Corresponding Author InformationCorresponding author. Institute of Psychiatry, University of Bologna, Viale Carlo Pepoli 5, 40123 Bologna, Italy. Tel.: +39 051 6584233; fax: +39 051 521030.

PII: S0924-977X(09)00260-0

doi:10.1016/j.euroneuro.2009.11.009


View previous. 2 of 12 View next.